Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AIM Vaccine Co., Ltd. Class H ( (HK:6660) ) has provided an announcement.
AIM Vaccine Co., Ltd. has announced a proposed adoption of a share incentive scheme aimed at promoting business development and accelerating its A Share Listing application. The scheme will offer share options or restricted shares to core personnel, not exceeding 5% of the total issued shares, with terms determined by the board and subject to shareholder approval.
More about AIM Vaccine Co., Ltd. Class H
AIM Vaccine Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the vaccine industry. The company focuses on developing, manufacturing, and distributing vaccines, aiming to enhance public health through innovative immunization solutions.
YTD Price Performance: -47.72%
Average Trading Volume: 6,404,183
Technical Sentiment Signal: Buy
For a thorough assessment of 6660 stock, go to TipRanks’ Stock Analysis page.